CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 77 filers reported holding CUE BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $163,000 | -62.0% | 33,467 | -11.8% | 0.00% | – |
| Q4 2021 | $429,000 | -23.0% | 37,927 | -0.8% | 0.00% | – |
| Q3 2021 | $557,000 | +76.3% | 38,236 | +40.9% | 0.00% | – |
| Q2 2021 | $316,000 | +29.0% | 27,136 | +35.2% | 0.00% | – |
| Q1 2021 | $245,000 | +22.5% | 20,071 | +25.4% | 0.00% | – |
| Q4 2020 | $200,000 | -13.0% | 16,007 | +4.7% | 0.00% | – |
| Q3 2020 | $230,000 | -44.8% | 15,292 | -10.2% | 0.00% | – |
| Q2 2020 | $417,000 | +154.3% | 17,023 | +47.4% | 0.00% | – |
| Q1 2020 | $164,000 | +92.9% | 11,546 | +14.6% | 0.00% | – |
| Q3 2019 | $85,000 | – | 10,072 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,545,573 | $3,447,000 | 1.85% |
| P.A.W. CAPITAL CORP | 200,000 | $446,000 | 0.67% |
| SANDERS MORRIS HARRIS LLC | 848,048 | $2,020,000 | 0.50% |
| Monaco Asset Management SAM | 458,851 | $1,023,000 | 0.39% |
| Bleichroeder LP | 555,000 | $1,238,000 | 0.26% |
| APOGEM CAPITAL LLC | 110,614 | $247,000 | 0.25% |
| Slate Path Capital LP | 1,483,619 | $3,308,000 | 0.22% |
| Voss Capital, LLC | 200,000 | $446,000 | 0.13% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $1,067,000 | 0.11% |
| CARLSON CAPITAL L P | 535,000 | $1,193,000 | 0.09% |